معرفی
Papia Basu Thakur is a Researcher affiliated with the Greif Lab at Yale School of Medicine, Yale University. She holds a PhD in Biological Sciences from the CSIR-Indian Institute of Chemical Technology (2024). Her research focuses on nanomedicine and materials science, particularly in cardiovascular and neurological diseases. Key areas include developing nanoparticle-based therapies for ischemia, epigenetic mechanisms in neural recovery, and applications of metallic nanomaterials in angiogenesis and wound healing.
Her work spans preclinical studies using animal models to evaluate nanoparticle efficacy, with a special emphasis on sex-specific differences in neuroinflammation and recovery post-ischemic injury. She has contributed to advancements in nanorod formulations (terbium, europium) for limb ischemia treatment and explored zinc oxide nanoparticles for cerebral ischemia. Her publications highlight interdisciplinary approaches integrating materials science with biomedical applications, such as fluorescence bioimaging and antibacterial nanotechnology.
While no formal advising roles or grants are listed, her research demonstrates significant innovation in nanomedicine for translational medicine. She is part of the Greif Lab, which likely focuses on vascular and neurological disease mechanisms.
